Similarly, the inhibition of NGF/TrkA signaling in PDAC with a pan-Trk inhibitor blocks NGF-dependent growth of murine PDAC cells, inhibits tumor growth, and increases the efficiency of chemotherapy. The gene discussed is NTRK1; the disease is neoplasm.